5.05
Immuneering Corp Azioni (IMRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
|
|
10.58%
13.75
|
15.38 | - | 15.48 | 18.56 |
| Operating Income/Loss |
10.58%
-13.75
|
-15.38 | - | -15.48 | -18.56 |
| Income/Loss From Continuing Operations Before Tax |
22.62%
-11.58
|
-14.96 | -14.43 | -15.05 | -18.05 |
| Income/Loss From Continuing Operations After Tax |
22.62%
-11.58
|
-14.96 | -14.43 | -15.05 | -18.05 |
|
|
22.62%
-11.58
|
-14.96 | -14.43 | -15.05 | -18.05 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
82.52%
6.9348
|
39.67 | - | 35.53 | 0.3589 |
| Diluted Average Shares |
82.52%
6.9348
|
39.67 | - | 35.53 | 0.3589 |
| Basic Earnings Per Share |
81.58%
-0.07
|
-0.38 | - | -0.42 | -0.59 |
| Diluted Earnings Per Share |
81.58%
-0.07
|
-0.38 | - | -0.42 | -0.59 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):